Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study

NCT03832673 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Regolatory National Agency (AIFA) not approved

Conditions

Muscle-invasive Bladder Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Epacadostat

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano